Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients
2023-07-27 08:53
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China
2023-07-27 08:10
SK Inc.'s board of directors declares an interim dividend of KRW 1,500 per share
2023-07-27 08:00
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023
2023-07-27 05:00
Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development
2023-07-27 04:00
CartiHeal Announces First Commercial Implantation of Agili-C™ in the US
2023-07-26 21:04
PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
2023-07-26 20:00
Philips Future Health Index 2023 Report: APAC's healthcare sector embracing new care delivery model to tackle financial pressures and staff shortages
2023-07-26 16:05
Samsung Biologics Reports Second Quarter 2023 Financial Results
2023-07-26 15:23
World's first*1 report: A potential effectiveness of Plasmacluster Technology that may induce brain activation
2023-07-26 14:15
Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023
2023-07-26 00:00
Alma, a Sisram Medical Company, Announces the Launch of Alma Veil™ for the U.S. Market
2023-07-25 22:10
Fapon Launches the Most Efficient Chemiluminescence Immunoassay Analyzer to Date with Throughput of 900 T/h
2023-07-25 20:07
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
2023-07-25 19:30
RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal
2023-07-25 16:00
Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023
2023-07-25 15:19
Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market
2023-07-25 14:00
Clinical Results of ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection Presented at the 12th IAS Conference on HIV Science
2023-07-25 08:10
Fapon to Showcase Innovative Diagnostic and Biopharma Solutions at 2023 AACC Expo
2023-07-24 21:58
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
2023-07-24 21:02
1
172
173
174
175
176
970